Cardiovascular Disease

Cardiovascular disease involves the heart and vessels and is the number one killer in the U.S. accounting for nearly 30-percent of all deaths. Cardiovascular disease has a number of forms but the most common are myocardial infarction and angina pectoris which affect the heart itself.

What is Cardiovascular Disease?

Diseases of disorders of this system are termed cardiovascular diseases. Cardiovascular diseases kill an estimated 17 million people worldwide each year. Majority of these are due to heart attacks and strokes.

Cardiovascular Benefits of Blueberries

Cardiovascular Disease Research

Lowering Risk for Cardiovascular Disease

Causes and Symptoms of Hypoplastic Left Heart Syndrome

Non-Communicable Diseases

Cardiovascular Drugs

What is Microvascular Endothelial Dysfunction?

Cardiovascular Disease Diagnosis

Latest Cardiovascular Disease News and Research

Swapping red meat for plant-based meat rapidly lowers a key heart risk metabolite, trial finds

A randomized crossover trial found that replacing red meat patties with processed plant-based meat alternatives for six days significantly lowered circulating trimethylamine N-oxide (TMAO), a gut-derived metabolite linked to cardiovascular risk. The plant-based phase also produced modest reductions in cholesterol markers but slightly increased weight and NT-proBNP, possibly due to higher sodium intake.

12 Mar 2026

Japanese study evaluates sleep architecture and safety of common insomnia drugs

OSA is a common sleep disorder characterized by oxygen desaturation due to repeated airway collapse during sleep.

12 Mar 2026

Can eating almonds reduce inflammation in obesity?

Adding almonds to the diet of adults with obesity enhances inflammatory cytokine profiles and diet quality, highlighting a simple anti-inflammatory strategy.

12 Mar 2026

Higher intake of ultra processed foods linked to weaker bones

From flavored yogurts to frozen pizzas, breakfast cereals and instant oats, ultra-processed foods are convenient, often cheaper items designed for a quick bite.

12 Mar 2026

Blood test marker p-tau217 helps detect early dementia risk in cognitively healthy older women

A long-term study of 2,766 women in the Women’s Health Initiative Memory Study found that higher baseline plasma p-tau217 levels were associated with a greater risk of developing mild cognitive impairment or probable dementia.

11 Mar 2026

Social isolation and loneliness raise cognitive decline risk in perimenopausal women

The relationship between social connections and cognitive abilities is a complex one, particularly during the perimenopausal period when women transition from the reproductive period to menopause.

11 Mar 2026

Cannabis, cocaine and amphetamines linked to higher stroke risk

Cannabis and other illicit drugs are associated with higher stroke risk, underscoring the importance of addressing substance use disorders in health strategies.

11 Mar 2026

Wegovy linked to higher risk of eye stroke and vision loss

Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of 'eye stroke' (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side effect reports published in the British Journal of Ophthalmology.

10 Mar 2026

Study reveals why US life expectancy gains stalled after decades of progress

A PNAS study analyzing US mortality from 1979 to 2023 reveals that life expectancy stagnation reflects both worsening outcomes in post-1950 birth cohorts and a broad mortality deterioration beginning around 2010. Cardiovascular mortality slowdowns, rising external causes, and cohort-specific patterns help explain the persistent decline in longevity gains.

10 Mar 2026

Study sheds new light on the link between cholesterol levels and mortality risks

A recent study published in Engineering has shed new light on the relationship between cholesterol levels and mortality risks.

10 Mar 2026

Postbiotics may help treat PCOS by restoring microbiome balance

Emerging studies suggest postbiotics could aid PCOS management by restoring gut microbiome balance and enhancing insulin sensitivity and hormonal regulation.

10 Mar 2026

Specific gut bacteria may signal long-term risk of heart and metabolic disease

Researchers analyzed gut microbiome profiles from 4,792 adults in the HELIUS cohort and tracked cardiometabolic outcomes over time to determine whether specific microbes predict disease risk. Certain microbes were linked to higher or lower cardiovascular risk, while plant-derived microbial metabolites suggested potential diet–microbiome interactions influencing heart health.

9 Mar 2026

American Heart Association ranked as a top trusted health information source

At time when trust in health information is at unprecedented risk, the American Heart Association today welcomed new findings from the independent Annenberg Public Policy Center (APPC) at the University of Pennsylvania suggesting that Americans consider the Association the most trusted source of public health information after their personal physician.

9 Mar 2026

Pregnancy complications increase heart health risks for women with high stress

Women who experience pregnancy complications, like preeclampsia, pre-term birth, stillbirth or having a baby that is small for gestational age, may face an increased risk for cardiovascular disease later in life.

9 Mar 2026

Med14 protein drives GLP-1 benefits in pancreatic beta cells

GLP-1s are building a reputation as "wonder drugs." First characterized for their ability to improve insulin release and treat diabetes, the drugs were later found to promote weight loss and improve cardiovascular health.

6 Mar 2026

Weekend lie-ins may boost insulin sensitivity, but too much may backfire

This study explores the relationship between sleep patterns and insulin sensitivity, emphasizing the impact of weekday sleep and weekend catch-up on metabolism.

6 Mar 2026

Drug combination shows greater weight loss while preserving muscle mass

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that blocks activin signaling pathways, results in greater weight loss while also preserving lean mass, such as skeletal muscle and connective tissue.

5 Mar 2026